Beyond interferon

doi:10.1038/nbt1207-1375

Nature Biotechnology 25, 1375

• Abstract
• Full Text
• PDF (126 KB)

Three decades of antiviral drugs

Erik De Clercq

doi:10.1038/nrd2485

Nature Reviews Drug Discovery 6, 941

• Abstract
• Full Text
• PDF (107 KB)

Hepatitis C: staying the course

Ken Garber

doi:10.1038/nbt1207-1379

Nature Biotechnology 25, 1379-1381

• Abstract
• Full Text
• PDF (223 KB)

Profile: Ian Frazer

Mark Ratner

doi:10.1038/nbt1207-1377

Nature Biotechnology 25, 1377

• Abstract
• Full Text
• PDF (94 KB)

An Audience With: Tadataka Yamada

doi:10.1038/nrd2481

Nature Reviews Drug Discovery 6, 950

• Full Text
• PDF (135 KB)

HIV combination products

Lisette Oversteegen, Mansi Shah & Holger Rovini

doi:10.1038/nrd2448

Nature Reviews Drug Discovery 6, 951-952

• Full Text
• PDF (431 KB)

Recent patent applications in antivirals

doi:10.1038/nbt1207-1405

Nature Biotechnology 25, 1405

• Full Text
• PDF (44 KB)

Antivirals—an increasingly healthy investment

Brian McCarthy

doi:10.1038/nbt1207-1390

Nature Biotechnology 25, 1390-1393

• Abstract
• Full Text
• PDF (149 KB)

Systems biology and the host response to viral infection

Seng-Lai Tan, Gopinath Ganji, Bryan Paeper, Sean Proll & Michael G Katze

doi:10.1038/nbt1207-1383

Nature Biotechnology 25, 1383-1389

• Abstract
• Full Text
• PDF (863 KB)

Bioinformatics prediction of HIV coreceptor usage

Thomas Lengauer, Oliver Sander, Saleta Sierra, Alexander Thielen & Rolf Kaiser

doi:10.1038/nbt1371

Nature Biotechnology 25, 1407-1408

• Abstract
• Full Text
• PDF (264 KB)

Antivirals: Mirror image inhibition

Monica Hoyos Flight

doi:10.1038/nrd2474

Nature Reviews Drug Discovery 6, 955

• Full Text
• PDF (141 KB)

Antivirals: MicroRNA versus virus: uncovering new layers of complexity

Alexandra Flemming

doi:10.1038/nrd2472

Nature Reviews Drug Discovery 6, 957

• Full Text
• PDF (364 KB)

HIV drug development: the next 25 years

Charles Flexner

doi:10.1038/nrd2336

Nature Reviews Drug Discovery 6, 959-966

• Abstract
• Full Text
• PDF (427 KB)

The war against influenza: discovery and development of sialidase inhibitors

Mark von Itzstein

doi:10.1038/nrd2400

Nature Reviews Drug Discovery 6, 967-974

• Abstract
• Full Text
• PDF (1,043 KB)

Albinterferon -2b: a genetic fusion protein for the treatment of chronic hepatitis C

G Mani Subramanian, Michele Fiscella, Araba Lamousé-Smith, Stefan Zeuzem & John G McHutchison

doi:10.1038/nbt1364

Nature Biotechnology 25, 1411-1419

• Abstract
• Full Text
• PDF (587 KB)

Interferons at age 50: past, current and future impact on biomedicine

Ernest C. Borden, Ganes C. Sen, Gilles Uze, Robert H. Silverman, Richard M. Ransohoff, Graham R. Foster & George R. Stark

doi:10.1038/nrd2422

Nature Reviews Drug Discovery 6, 975-990

• Abstract
• Full Text
• PDF (708 KB)

The way forward in HCV treatment — finding the right path

Michael P. Manns, Graham R. Foster, Jürgen K. Rockstroh, Stefan Zeuzem, Fabien Zoulim & Michael Houghton

doi:10.1038/nrd2411

Nature Reviews Drug Discovery 6, 991-1000

• Abstract
• Full Text
• PDF (816 KB)

The design of drugs for HIV and HCV

Erik De Clercq

doi:10.1038/nrd2424

Nature Reviews Drug Discovery 6, 1001-1018

• Abstract
• Full Text
• PDF (1,966 KB)
• Supplementary information

The growth and potential of human antiviral monoclonal antibody therapeutics

Wayne A Marasco & Jianhua Sui

doi:10.1038/nbt1363

Nature Biotechnology 25, 1421-1434

• Abstract
• Full Text
• PDF (1,329 KB)

RNA interference against viruses: strike and counterstrike

Joost Haasnoot, Ellen M Westerhout & Ben Berkhout

doi:10.1038/nbt1369

Nature Biotechnology 25, 1435-1443

• Abstract
• Full Text
• PDF (1,086 KB)

Genetic therapies against HIV

John J Rossi, Carl H June & Donald B Kohn

doi:10.1038/nbt1367

Nature Biotechnology 25, 1444-1454

• Abstract
• Full Text
• PDF (1,879 KB)

Antiviral drug discovery and development

doi:10.1038/nrd2483

Nature Reviews Drug Discovery 6, 1019

• Abstract
• Full Text
• PDF (247 KB)